Nanobiotechnology and Nanomedicine Companies
Showing results 1 - 20 of 28 for companies in category Biomaterials in USA:
The firm commercializes a family of self-assembling nanoscale scaffolds called PuraMatrix. 3DM's materials assemble upon injection into nanofibers, serving as a scaffold for tissue regeneration.
The company develops biomedical nanoparticle technology and products for research and treatment of human disease. They are developing NanoElectroPlex™, a proprietary tissue selective nanoparticle platform technology based on biodegradable macromolecular carriers.
The company has developed enabling nanotechnologies for the production of protein nanoparticles, polymer nanospheres and phospholipid nanosomes for the enhanced delivery of drugs.
ApoLife has developed platform yeast expression technologies for accelerated development of therapeutic antibodies (glycosylated and aglycosylated), antibody fragments, fusion proteins and next generation antibodies and subunit vaccines through its proprietary Twin Cassette yeast system.
Develops a nanostructured material that stops bleeding almost instantly.
Arrayit Corporation empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
AuraSense's uniquely engineered nanoparticles possess unparalleled biocompatibility and versatility as therapeutics and as novel assays within live cells. They hold great promise for combating the most threatening diseases, including heart disease, cancer, and bacterial infection.
BIND Biosciences, Inc. is a biopharmaceutical company developing therapeutic targeted nanoparticles.
Dental implant technology with nanoscale coatings.
The company is developing its proprietary calcium phosphate nanotechnology (CAP) for novel vaccines, including biodefense vaccines for toxins such as anthrax and ricin, and drug delivery systems.
Celsense is a biotechnology company offering novel MRI contrast agents (fluorochemical nanoparticles) that allow scientists and clinicians to monitor the position and quantity of transplanted cells non-invasively in vivo.
Develops a family of nanocomposite materials designed to increase mechanical performance in medical applications.
Develops proprietary nanoengineered polymer materials and products based on these materials for a broad range of applications.
A biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines, based on its nanotechnology platform.
NanoBiotech is a broad-based life science company that discovers, develops, manufactures and markets a range of nanobiotics and medical diagnostics designed to improve people's health and longevity.
Nanoparticle Biochem was established through unique and original discoveries on the design and development of various types of metallic nanoparticles and bioconjugates by its co founders. Its mission is to apply the principles of nanoscience and nanotechnology to derive imaging and therapy products to ultimately help the patients community, directly or indirectly, in alleviating pain and suffering. NBI's niche in antibacterial and antifungal technologies has allowed the development of sophisticated antifungal agents for applications in the field of human hygiene and agriculture.
Design, synthesis, and analysis of small molecule organic compounds for the pharmaceutical industry.
A specialty pharmaceutical company that targets and transforms approved pharmaceuticals and new chemical entities using their neuNanoParticle technology.
Novavax is focused on creating novel, highly potent recombinant vaccines produced via cell culture. The company has developed three proprietary technology platforms: Virus-Like Particles, NovasomeŽ paucilamellar vesicles and Micellar Nanoparticles.
Develops, manufactures and commercializes medical products based on nanocrystalline silver technology.
